Pierce and Wondering Why....
His departure surely made me wonder why.
BTW, his linked-in page clearly says that he is
"Providing scientific, translational biology and early clinical development expertise to immune-oncology companies, spanning immune-modulatory small molecules, intratumoral gene therapy and therapeutic vaccine approaches."
and that he counts ONCS among his clients.